FGP Capital

It primarily targets investments in healthcare drug discovery and disruptive engineering solutions. The team provides growth capital to life science and technology companies with a focus on European and Swiss markets. They aim for short-to-medium holding periods through active involvement in M&A activities. Typical investment structures include straight equities and convertible bonds to support clinical research and development.